Literature DB >> 18542109

Endocrine abnormalities in anorexia nervosa.

Elizabeth A Lawson1, Anne Klibanski.   

Abstract

Anorexia nervosa (AN) is a psychiatric disease associated with notable medical complications and increased mortality. Endocrine abnormalities, including hypogonadotropic hypogonadism, hypercortisolemia, growth hormone resistance and sick euthyroid syndrome, mediate the clinical manifestations of this disease. Alterations in anorexigenic and orexigenic appetite-regulating pathways have also been described. Decreases in fat mass result in adipokine abnormalities. Although most of the endocrine changes that occur in AN represent physiologic adaptation to starvation, some persist after recovery and might contribute to susceptibility to AN recurrence. In this Review, we summarize key endocrine alterations in AN, with a particular focus on the profound bone loss that can occur in this disease. Although AN is increasingly prevalent among boys and men, the disorder predominantly affects girls and women who are, therefore, the focus of this Review.

Entities:  

Mesh:

Year:  2008        PMID: 18542109     DOI: 10.1038/ncpendmet0872

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  29 in total

1.  Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index.

Authors:  Elizabeth A Lawson; Kamryn T Eddy; Daniel Donoho; Madhusmita Misra; Karen K Miller; Erinne Meenaghan; Janet Lydecker; David Herzog; Anne Klibanski
Journal:  Eur J Endocrinol       Date:  2010-11-23       Impact factor: 6.664

2.  The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study.

Authors:  D S Pisetsky; S E Trace; K A Brownley; R M Hamer; N L Zucker; P Roux-Lombard; J-M Dayer; C M Bulik
Journal:  Cytokine       Date:  2014-06-14       Impact factor: 3.861

Review 3.  Interacting Neural Processes of Feeding, Hyperactivity, Stress, Reward, and the Utility of the Activity-Based Anorexia Model of Anorexia Nervosa.

Authors:  Rachel A Ross; Yael Mandelblat-Cerf; Anne M J Verstegen
Journal:  Harv Rev Psychiatry       Date:  2016 Nov/Dec       Impact factor: 3.732

4.  Pituitary immunoexpression of ghrelin in anorexia nervosa.

Authors:  Fabio Rotondo; Bernd W Scheithauer; Luis V Syro; Angelo Rotondo; Kalman Kovacs
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

5.  Peptide tyrosine tyrosine levels are increased in patients with urea cycle disorders.

Authors:  Sabrina Mitchell; Teresa Welch-Burke; Logan Dumitrescu; Jefferson P Lomenick; Deborah G Murdock; Dana C Crawford; Marshall Summar
Journal:  Mol Genet Metab       Date:  2012-02-22       Impact factor: 4.797

Review 6.  Why does starvation make bones fat?

Authors:  Maureen J Devlin
Journal:  Am J Hum Biol       Date:  2011-07-25       Impact factor: 1.937

7.  Caloric restriction leads to high marrow adiposity and low bone mass in growing mice.

Authors:  Maureen J Devlin; Alison M Cloutier; Nishina A Thomas; David A Panus; Sutada Lotinun; Ilka Pinz; Roland Baron; Clifford J Rosen; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2010-09       Impact factor: 6.741

Review 8.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

9.  Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa.

Authors:  Elizabeth A Lawson; Daniel Donoho; Karen K Miller; Madhusmita Misra; Erinne Meenaghan; Janet Lydecker; Tamara Wexler; David B Herzog; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study.

Authors:  Elizabeth A Lawson; Pouneh K Fazeli; Genevieve Calder; Hannah Putnam; Madhusmita Misra; Erinne Meenaghan; Karen K Miller; Anne Klibanski
Journal:  J Clin Psychiatry       Date:  2012-11       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.